Semi-automation of keratopathy visual acuity grading of corneal events in belantamab mafodotin clinical trials: clinical decision support software

BACKGROUND: Belantamab mafodotin (belamaf) has demonstrated clinically meaningful antimyeloma activity in patients with heavily pretreated multiple myeloma. However, it is highly active against dividing cells, contributing to off-target adverse events, particularly ocular toxicity. Changes in best c...

Descripción completa

Detalles Bibliográficos
Autores principales: Talekar, Mala K., Painter, Jeffery L., Elizalde, Mica A., Thomas, Michele, Stein, Heather K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Digital Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597720/
https://www.ncbi.nlm.nih.gov/pubmed/37881364
http://dx.doi.org/10.3389/fdgth.2023.1138453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597720/
https://www.ncbi.nlm.nih.gov/pubmed/37881364
http://dx.doi.org/10.3389/fdgth.2023.1138453

Ejemplares similares